3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
5
Ototoxicity
4
Medulloblastoma
4
Hepatoblastoma
4
Central Nervous System Neoplasms
4
Peritoneal Neoplasms
3
Ovarian Neoplasms
3
Gastrointestinal Neoplasms
3
Drug-Related Side Effects and Adverse Reactions
3
Testicular Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Oligodendroglioma
2
Neoplasms, Germ Cell and Embryonal
2
Liver Neoplasms
2
Hearing Loss
2
Glioma
2
Brain Neoplasms
2
Astrocytoma
2
Adrenocortical Carcinoma
2
Thrombocytopenia
1
Teratoma
1
Seminoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Optic Nerve Glioma
1
Interventions
Doxorubicin
25
Radiotherapy
15
Ifosfamide
14
Trabectedin
10
pazopanib
6
ribociclib
5
pembrolizumab
5
Specimen Handling
5
Gemcitabine
5
Biopsy
5
palbociclib
4
Magnetic Resonance Spectroscopy
4
Docetaxel
4
Chemotherapy, Adjuvant
4
selinexor
3
liposomal doxorubicin
3
eribulin
3
X-Rays
3
Vincristine
3
Radiation
3
Neoadjuvant Therapy
3
Imatinib Mesylate
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
toripalimab
2
temsirolimus
2
romidepsin
2
pegfilgrastim
2
cixutumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liposarcoma
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled